[go: up one dir, main page]

FI20135503L - Cysteine or its derivative for the treatment of atrophic gastritis - Google Patents

Cysteine or its derivative for the treatment of atrophic gastritis Download PDF

Info

Publication number
FI20135503L
FI20135503L FI20135503A FI20135503A FI20135503L FI 20135503 L FI20135503 L FI 20135503L FI 20135503 A FI20135503 A FI 20135503A FI 20135503 A FI20135503 A FI 20135503A FI 20135503 L FI20135503 L FI 20135503L
Authority
FI
Finland
Prior art keywords
cysteine
derivative
treatment
atrophic gastritis
atrophic
Prior art date
Application number
FI20135503A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI20135503A7 (en
Inventor
Osmo Suovaniemi
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20135503A priority Critical patent/FI20135503L/en
Priority to EA201591994A priority patent/EA201591994A1/en
Priority to HK16111568.1A priority patent/HK1223284A1/en
Priority to PCT/FI2014/050351 priority patent/WO2014184435A1/en
Priority to EP14797478.6A priority patent/EP2996687A4/en
Priority to CN201480039914.7A priority patent/CN105492002A/en
Publication of FI20135503A7 publication Critical patent/FI20135503A7/en
Publication of FI20135503L publication Critical patent/FI20135503L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI20135503A 2013-05-13 2013-05-13 Cysteine or its derivative for the treatment of atrophic gastritis FI20135503L (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20135503A FI20135503L (en) 2013-05-13 2013-05-13 Cysteine or its derivative for the treatment of atrophic gastritis
EA201591994A EA201591994A1 (en) 2013-05-13 2014-05-12 CYSTEIN OR ITS DERIVATIVE FOR THE TREATMENT OF ATROPHIC GASTRITIS
HK16111568.1A HK1223284A1 (en) 2013-05-13 2014-05-12 Cysteine or a derivative thereof for the treatment of atrophic gastritis
PCT/FI2014/050351 WO2014184435A1 (en) 2013-05-13 2014-05-12 Cysteine or a derivative thereof for the treatment of atrophic gastritis
EP14797478.6A EP2996687A4 (en) 2013-05-13 2014-05-12 CYSTEINE OR DERIVATIVE ASSOCIATED WITH THE TREATMENT OF ATROPHIC GASTRITIS
CN201480039914.7A CN105492002A (en) 2013-05-13 2014-05-12 Cysteine or a derivative thereof for the treatment of atrophic gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20135503A FI20135503L (en) 2013-05-13 2013-05-13 Cysteine or its derivative for the treatment of atrophic gastritis

Publications (2)

Publication Number Publication Date
FI20135503A7 FI20135503A7 (en) 2014-11-14
FI20135503L true FI20135503L (en) 2014-11-14

Family

ID=51897812

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20135503A FI20135503L (en) 2013-05-13 2013-05-13 Cysteine or its derivative for the treatment of atrophic gastritis

Country Status (6)

Country Link
EP (1) EP2996687A4 (en)
CN (1) CN105492002A (en)
EA (1) EA201591994A1 (en)
FI (1) FI20135503L (en)
HK (1) HK1223284A1 (en)
WO (1) WO2014184435A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20216361A1 (en) * 2021-12-29 2023-06-30 Biohit Oyj Use of L-cysteine to improve the structure and function of the gastric mucosa
EP4465048A1 (en) * 2023-05-16 2024-11-20 Biohit Oyj Quick test combination for screening of dyspepsia and other abdominal symptoms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI122914B (en) * 2005-04-01 2012-08-31 Biohit Oyj Food composition for binding of acetaldehyde in the mouth and in the digestive tract and process for the preparation of the composition
FI20060501A7 (en) * 2006-05-22 2007-11-23 Biohit Oyj Composition and method for binding acetaldehyde in the stomach
FI20065542A0 (en) * 2006-09-01 2006-09-01 Biohit Oyj Method and Sampling Kit for Assessment of Abdominal Mucosal Condition
CN102316730A (en) * 2008-05-09 2012-01-11 天雅瑞药业有限公司 Controlled release of N-acetylcysteine (NAC) for reduction of systemic and/or vascular inflammation
FI20115377A (en) * 2011-04-18 2012-10-19 Biohit Oyj Medical products for use in conditions related to microbial infections of upper respiratory and digestive organs
BR112015006048A2 (en) * 2013-03-12 2017-07-04 Biohit Oyj encapsulated composition for bonding with stomach aldehydes

Also Published As

Publication number Publication date
HK1223284A1 (en) 2017-07-28
EP2996687A4 (en) 2016-12-07
EA201591994A1 (en) 2016-05-31
EP2996687A1 (en) 2016-03-23
WO2014184435A1 (en) 2014-11-20
CN105492002A (en) 2016-04-13
FI20135503A7 (en) 2014-11-14

Similar Documents

Publication Publication Date Title
IL244388A0 (en) Cyclic peptide-like compounds as immunomodulators
AR095266A1 (en) TETRACICLIC BROMODOMINES INHIBITORS
HRP20181679T1 (en) AMID COMPOUNDS FOR THE TREATMENT OF HIV
ME03336B (en) DNA-PK INHIBITORS
LT3080100T (en) LYSINE-SPECIFIC DEMETHYLASE-1 INHIBITORS
LT3057586T (en) BROMODOMENE INHIBITORS
EP2970173A4 (en) INHIBITORS OF THE KYNURENIN PATHWAY
EP2969007A4 (en) HISTONDEMETHYLASE INHIBITORS
HRP20180460T1 (en) SYK INHIBITORS
HUE061618T2 (en) Compound for the treatment of eye disorders
PL3007695T3 (en) COMPOSITIONS AND METHODS FOR TREATING ANEMIA
FR3015434B1 (en) TURBOMACHINE SUSPENSION
HUE046470T2 (en) Isochromene derivatives as inhibitors of phosphoinositide-3-kinases
EP2961806A4 (en) ANTI-COUNTERFEIT HOUSING
LT3007726T (en) METHODS OF TREATMENT OF TAUTOPATHY
EP2863748A4 (en) INHIBITORS OF 1,2,4-TRIAZINE-6-CARBOXAMIDE KINASE
EP3632467C0 (en) INHIBITORS OF COMPLEMENT FACTOR H
EP2945942A4 (en) IMMUNODOSAGES OF VIROCONAZOLE
HUE046723T2 (en) Filler composition for the treatment of lipoatrophy
FR3001759B1 (en) ROUGE AUBAGEE OF TURBOMACHINE
FI20135866L (en) MICROBIOLOGICAL PROCESSING OF KERATIN
EP2948557A4 (en) PURIFICATION OF CADAVERINE
BR112016010457A2 (en) MODIFICATION OF POLYAMIDES
BR112016002104A2 (en) 3-oxopent-4-enoyl-coa synthesis method
CL2016000616A1 (en) Heterocyclic compounds of n-acylimino.

Legal Events

Date Code Title Description
MM Patent lapsed